Introduction
Universal health coverage (UHC) is high on the political agenda of many low- and middle-income countries (LMICs), and developing an effective health financing system is particularly important for advancing this agenda.1–3 Health purchasing is one of the three main functions of any health financing system, along with revenue collection and pooling.4 The purchasing function consists of ‘the transfer of pooled resources to service providers on behalf of the population for which the funds were pooled’4 (p. 180). How this function is enacted determines the extent to which health financing is efficient, equitable and supportive of UHC goals.2 5 In this regard, there is a consensus among experts that health purchasing should be strategic rather than passive.6 7 Passive purchasing, for example, involves the automatic allocation of funds to providers on a historical basis, with no supporting documents or prior assurance that appropriate and quality services have been provided.8 In contrast, strategic health purchasing involves, at a minimum, monitoring providers and linking their payment to their performance and/or the health needs of the population they serve.7 However, the classification of purchasing into passive and strategic is more for heuristic purposes, as the reality is far from such a binary approach—it is rather a continuum between these two extremes.6
While strategic health purchasing is now well conceptualised7 9 10 and is more and more researched,11–13 it is still not yet always interpreted in the same way.14 For instance, strategic health purchasing has sometimes been confused with14 or assumed to have many similarities with specific schemes such as results-based financing.15–17 Others argue that it should not be seen as a specific policy or scheme, but rather as a set of policy tools that policy/decision-makers can use effectively to improve the impact of UHC-related policies—the so-called ‘functional approach to strategic health purchasing’.18 This functional approach focuses on strategic thinking about what services to buy, for whom, from whom to buy them, how to pay providers and at what rate and frequency, what reliable information system to put in place that would accurately report on provider performance, what governance mechanisms to put in place to oversee and regulate the whole system.
These different approaches to strategic health purchasing indicate that there are still open questions about how to operationalise it in a specific setting. There is no single blueprint, and each country must find its own way forward. Indeed, achieving such operationalisation is complex, for at least three reasons. First, the complexity lies in the way strategic health purchasing is framed, communicated, understood and applied in practice by policy actors—it is a relatively new concept in LMICs and not a very intuitive one. Second, in most countries, strategic health purchasing could suggest a broad, substantial and challenging agenda for health system reform.13 Third, strategic health purchasing is not a one-size-fits-all solution that can be implemented in a standard way across countries. These elements suggest that policy learning is a crucial factor for countries aiming to advance towards strategic health purchasing and, consequently, towards UHC. This perspective has been previously articulated by numerous scholars in the field.19–22
Policy learning has been approached and conceptualised in different ways by political scientists,23–26 and it is difficult to find common ground on how to make it actionable. This challenge also results in a dearth and fragmentation of empirical studies on policy learning.27 Dunlop and Radaelli define policy learning as ‘the updating of beliefs based on lived or witnessed experiences, analysis or social interaction’ (p. 599).28 Policy learning gained prominence when Heclo drew attention to the importance of knowledge and ideas in politics and policy processes: ‘Politics finds its sources not only in power but also in uncertainty—men collectively wondering what to do. […]. Governments not only ‘power’ (or whatever the verb form of that approach might be); they also puzzle. Policy-making is a form of collective puzzlement on society’s behalf; it entails both deciding and knowing’ (p. 305).29 Several conceptions, theories and analytical frameworks related to learning have subsequently emerged, such as Heclo’s ‘political learning’,29 Etheredge’s ‘governmental learning’,30 Sabatier’s ‘policy-oriented learning’,31 Rose’s ‘lesson-building’32 and Hall’s ‘social learning’.33 A bibliometric analysis of learning by Goyal and Howlett in 2018 confirms this fragmentation, showing that political scientists work in silos and do not learn enough from each other’s work,23 which hinders progress in operationalising the concept.
Learning is often valued for its result, that is, as an outcome, but it is also a process. For example, Bennett and Howlett25 suggest looking at learning through three key elements: Who is learning? What is being learnt? To what effect(s)? Regarding learners, Moyson et al34 found that they can be at a microlevel, involving individuals or groups/teams; at a mesolevel, involving organisations; or at a macrolevel, pertaining to learning across organisations or government units, for example, through policy transfer,35 policy diffusion36–38 or lesson-drawing.32 As for learning contents, Vagionaki and Trein39 assert that policy actors can learn about new information and ideas, or about specific policy instruments (eg, laws and regulations, market-based incentives, taxes, subsidies, information control). The most common outcomes expected from learning are positive changes, but these are far from being automatic and clear-cut. In fact, several other factors also influence policy change, such as political economy or path dependency.40 Moreover, learning itself and the changes it is intended to bring about are difficult to materialise, capture and measure.24 34 In addition, learning can be inefficient or go wrong, if some scope conditions are not met,41 42 or if, for example, the wrong teachers are listened to or the wrong lessons are implemented.41 43 44
Despite the extensive literature on ‘evidence to policy’,45 and the growing interest of global health actors and researchers in learning in the health sector,19–22 46–49 some aspects of ‘learning health systems’ and ‘learning for UHC’ in low-income countries remain under-researched. For example, while it is recognised that learning is an important component of the policy process,21 43 50 few studies in the health sector have taken a policy learning perspective to investigate it empirically and to examine and infer the modes of learning that shape or result from policy-making. Dunlop and Radaelli have shown that policy learning can be either epistemic, reflexive, bargaining-oriented or hierarchical,28 and that these modes of learning reflect characteristics of the policy process.43 In a previous paper, we have already shown that such a conceptualisation of learning is relevant and potentially applicable in the health sector, particularly in UHC processes.22
This paper aims to go further and illustrate policy learning empirically by examining the introduction of strategic health purchasing in Burkina Faso and efforts to translate it into policy and practice. Specifically, our work seeks to provide insights into how learning, as an important component of the policy process, can shape it and contribute to understanding some of the challenges associated with building a coherent health financing system in a resource-constrained country like Burkina Faso—a country that has undertaken major health financing reforms in recent years.51–53 To achieve these objectives, our research questions (RQ) are as follows:
RQ 1. What modes of learning have or have not been used in the process aiming at translating strategic health purchasing into policy and practice?
RQ 2. What helped or hindered learning to occur?
RQ 3. How have these learning or missed learning opportunities affected the outcomes of the processes of translating strategic health purchasing into policy and practice?
Study context
To improve access to and quality of healthcare for its population, the government of Burkina Faso has introduced several health financing policies. These included (1) the national policy of subsidising 80% of the direct medical costs of emergency obstetric and neonatal care,54 55 known as ‘SONU’, which was implemented between 2006 and 2015 and was fully financed by the national budget; (2) the pilot phase of a performance-based financing (PBF) scheme between 2011 and 201856–58 or (3) the national user fee exemption policy for women and children under 5 years of age since 2016, known as ‘gratuité’,59–61 which has replaced ‘SONU’ and is still ongoing.
The process of adopting and formulating health policies in Burkina Faso can be described as following different pathways. It may be that the government initiates the policy development process and commissions technical departments or experts to propose and evaluate different alternatives. This is exemplified by ‘SONU’.54 Alternatively, ideas or initiatives may originate from civil society, non-governmental organisations (NGOs), associations or pressure groups, or from technicians lobbying politicians or decision-makers to adopt new or revised policies. This second scenario may be achieved by taking advantage of windows of opportunity, such as elections or social movements, as was the case with ‘gratuité’.62 These health policies are more likely to be endorsed and funded by the national budget, thereby ensuring a certain degree of sustainability. Another scenario is that of donor-funded projects and programmes, which often present sustainability challenges when funding ends while there is a lack of government or national ownership, or when the policy has not been institutionalised. This was evidenced by the experience of the PBF scheme.63
PBF was initially introduced in Burkina Faso in 2011 by the government as a pilot intervention in three health districts (out of 63 districts) with the financial support of the World Bank (WB), following a study tour in Rwanda. PBF links funds, payments or bonuses to health service providers based on results achieved against predefined quality and quantity criteria. It affords these providers a degree of autonomy in the utilisation of these resources. The rationale for introducing PBF was to improve the use and quality of maternal and child health services. After initial promising results, the government decided in 2014 to expand the pilot project to 12 health districts (out of 63) in six regions (out of 13), with continued financial support from the WB. Following a reorganisation of the health district map in 2015, which resulted in the splitting of some health districts, the total number of districts covered by PBF increased to 19 (out of 70). To implement PBF, a National Technical Unit was set up in 2014, comprising national technical assistants and policy-makers. The technical assistants had previous experience in implementing PBF, either acquired in Burkina Faso between 2011 and 2013 or in other countries. They received training in PBF from Sina Health,64 with some of them subsequently assuming the role of PBF trainers. They were tasked with transferring their expertise to policy-makers. Both the technical assistants and the policy-makers had vested interests and technical authority, but they had limited decision-making power on whether to continue PBF after the pilot phase.
‘Gratuité’ is almost 100% funded by the state budget and was previously piloted by international NGOs in five health districts since 2007.62 65–68 The policy was formulated and implemented by policy-makers involved in the pilot projects. These policy-makers had both the technical expertise, the necessary political support and the decision-making power to devise the policy and draft the guidelines essential for its successful implementation. Following a 2-month pilot phase in three regions, ‘gratuité’ was rolled out nationally in all public health facilities. For children under the age of 5, all direct medical costs related to curative care are covered, with a focus on the conditions and diseases included in the country’s Integrated Management of Childhood Illnesses strategy. For women, ‘gratuité’ provides comprehensive coverage for women’s healthcare needs related to pregnancy, encompassing antenatal care, childbirth and postpartum care up to 42 days after childbirth. The benefit package also includes the screening and treatment of precancerous lesions of the cervix, the physical examination of the breasts (for the early detection of breast cancer) and the treatment of obstetric fistulas. Funds are disbursed to health facilities on a quarterly basis under a third-party payment system. In this system, the state acts on behalf of the target population to pay for healthcare on a fee-for-service basis.
In introducing ‘gratuité’, the government of Burkina Faso was concerned about the increasing fragmentation of health financing and considered how this policy could be complementary and synergistic with PBF to avoid duplication of payments and allow each scheme to build on the strengths and assets of the other. The Secretary General of the Ministry of Health (MOH) therefore asked PBF and ‘gratuité’ policy-makers, that is, senior technicians, to reflect on how the two schemes can be coupled to make their purchasing function more efficient and performing. The concept of ‘strategic health purchasing’ thus emerged to brand this coupling and to achieve the latter four meetings were held in August 2016, March 2017, April 2017 and October 2017. The aim of the first meeting was to identify where the two schemes converged and diverged and what needed to be harmonised or changed to facilitate their coupling. The other three meetings were set up to develop a ground document for the implementation of a coupling strategy, including the definition of key principles for the coupling, the development of technical and financial management tools, and the conditions for successful implementation. These four meetings received financial support from the WB which sought to use this coupling as the basis for component 1 of the Health Services Reinforcement Project (HSRP), its new operation planned for 2018–2023, a successor to PBF. Each of these meetings ended with recommendations, but they were never implemented until the next meeting, which contributed to the coupling that was expected to lead to a new health financing scheme not being achieved by 2020.
Given this situation and the stalemate in the process, the idea of coupling PBF and ‘gratuité’ was abandoned. Instead, the MOH, in agreement with the WB, which was concerned about the low disbursement of funds for component 1 of the HSRP, decided to implement strategic health purchasing mechanisms only through ‘gratuité’. The HSRP was subsequently restructured to reflect these changes. However, like the coupling, the integration of strategic health purchasing approaches into ‘gratuité’ proved to be elusive. Indeed, disputes arose over how to proceed, prompting the Minister of Health to request technical assistance from the Strategic Purchasing Africa Resource Centre (SPARC) in February 2020 to help operationalise strategic health purchasing.69 SPARC is a resource hub launched in 2017 by the international NGO Results for Development, with funding from the Bill and Melinda Gates Foundation.70 From 2022, SPARC is hosted by the international NGO Amref Health Africa and aims to build and support capacity in strategic health purchasing across sub-Saharan Africa.
SPARC’s support to the MOH began in the last quarter of 2020 and was still ongoing at the time of writing. In September 2020, an initial consultative meeting was held with key MOH stakeholders to clarify needs and priority interventions, including (1) building a common understanding of what strategic health purchasing is and what it entails; (2) getting component 1 of the HSRP back on track, as its implementation had been severely delayed and (3) developing and implementing a roadmap for the overall strengthening of strategic health purchasing.